Cargando…
长链非编码RNA在非小细胞肺癌EGFR-TKIs耐药中的研究进展
Most non-small cell lung cancer patients with active epidermal growth factor receptor (EGFR) mutation will eventually acquire drug resistant to EGFR tyrosine kinase inhibitors, such as gefitinib, resulting in disease progression, which involves a variety of complex mechanisms. Up to now, the molecul...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973017/ https://www.ncbi.nlm.nih.gov/pubmed/29526180 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.02.06 |